renal tumor
Conditions
Interventions
control group 1:robot-assisted, conventional suture techniques
experimental group 1:robot-assisted, argon-beam-coagulator suture-free
experimental group 2:argon-beam-coagulator suture-free
control group 2:conventional suture techniques
Sponsors
Shanghai Ninth People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. T1a stage renal tumors, that is, the maximum diameter of the tumor is <= 4 cm; 2. Women of childbearing age should agree to use contraceptive measures (such as intrauterine devices, contraceptives or condoms) during the study period and within 12 months after the end of the study; they must be non-lactating patients; 3. Agree to complete various inspections required by the project, including 4 times of nuclide renal dynamic GFR within one year.
Exclusion criteria
Exclusion criteria: 1. Completely endogenous tumor; 2. Preoperative diagnosis of renal hamartoma; 3. Patients with general anesthesia contraindications; 4. Combined with other diseases that may affect the patient's renal function during the study period (judged by the investigator).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| change of GFR of affected kidney in 1 year; | — |
Secondary
| Measure | Time frame |
|---|---|
| change of GFR of affected kidney in 1, 3, 6 month;change of eGFR in 1, 3, 6 month;Time of surgery;blood loss;warm ischemia time; | — |
Countries
China
Contacts
Public ContactBin Xu
Shanghai Ninth People's Hospital
Outcome results
None listed